OnKure Therapeutics, Inc. (NasdaqGM: OKUR)
Health Care · Biotechnology · US
$2.35
-2.70% today · -16.3% 1Y
OnKure Therapeutics, Inc. (NasdaqGM: OKUR) operates in the Biotechnology industry within the Health Care sector. The company is valued at $97.60M and employs 45 people.
Over the last twelve months the share price has lost 16.3%, trading between 2.13 and 5.38.
Tweenvest scores OnKure Therapeutics, Inc. across four factors: quality 44/100, value 46/100. Its strongest factor is value.
OKUR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $97.60M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -2.58
- Dividend yield
- —
- Beta (5Y)
- 0.75
- 52-week high
- $5.38
- 52-week low
- $2.13
- Avg volume (3M)
- —
- Shares outstanding
- 40.50M
- Employees
- 45
- Next earnings
- —
About OnKure Therapeutics, Inc.
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.
- ISIN
- US68277Q1058
- Founded
- 2011
- Listed since
- Apr 8, 2021
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| HST Global, Inc.OTCPK: HSTC | $99.00M | $0.70 | +600.00% |
| Biomea Fusion, Inc.NasdaqGS: BMEA | $98.58M | $1.26 | -7.35% |
| Genexine, Inc.KOSDAQ: A095700 | $98.27M | ₩2,905.00 | +4.87% |
| Novogenia AGMUN: 7V0 | $98.11M | €7.20 | — |
| CanBas Co., Ltd.TSE: 4575 | $96.69M | ¥801.00 | +8.39% |
| Energenesis Biomedical CO.,LTD.TWSE: 6657 | $95.81M | NT$34.85 | +5.93% |
| Senhwa Biosciences, Inc.TPEX: 6492 | $94.77M | NT$33.90 | -1.45% |
| SynAct Pharma ABOM: SYNACT | $94.64M | Skr17.20 | +1.78% |
Figures last refreshed Oct 11, 2026.